Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments

Key Points

• The research aims to identify predictors of outcomes in patients experiencing progressive multifocal leukoencephalopathy (PML) related to multiple sclerosis treatments.
• Analyzed clinical data from patients diagnosed with PML related to MS treatments.
• Evaluated the impact of interventions like PlEx and corticosteroids.
• Examined the management strategies concerning PML-IRIS.
• Identified key predictors that influence the outcomes of PML in MS patients.
• Demonstrated that PlEx and corticosteroids impact the management of iatrogenic PML.
• Highlighted considerations for managing PML-IRIS effectively.